RE: Right, quiet please, its about to begin.25 Jun 2021 16:21
Yes, it was excellent, Vlad did not mention CLNs or Mint once which was surprising!!!
Funding situation is excellent, made it clear no need to fund raise any time soon
CAR-T - Did not want to commit to timescale but made it clear he believes it will be first in clinical trials in the near future.
CDX - Basically said Global co have alot of manpower, Lawyers, scientists, Intellectual Property experts working on the licencing agreement to cover pre-clinical, the clinical trials themselves and protections and licensing on the clinical candidate. They are going to test on AML first but provided that goes well the aim is to widen the scope to cover a massive list of indications requiring bone marrow transplant, IE a replacement for Chemotherapy.
CBR - they have repeated the results in the lab, it works, but they are holding off publishing anything until the IP is protected because its so novel and at this time no known competition.
One slide for Summary says in relation to mice: "represent an immediate income source for the company"
Only spent 6.15m in the lifetime of the company.
Several patents filed for CDX, we only know of one that has been granted.
So thats it, All positive, nothing negative, he deliberately and efficiently avoided answering anything with a time frame or date, we have zero idea when anything will land, makes it more exciting :-)